Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half

Restarting antiplatelet therapy after intracranial hemorrhage remains controversial, but new evidence suggests aspirin or clopidogrel can significantly reduce recurrent ICH without increased bleeding.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news